mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.6 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.2 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0004 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.8 |